468 research outputs found
DIET QUALITY AND CALORIES CONSUMED: THE IMPACT OF BEING HUNGRIER, BUSIER AND EATING OUT
While Americans claim to be eating better and improving their understanding of diet and health, they are getting heavier and increasing their risk of suffering from diet related illnesses. The cause of this inconsistency is unclear. Using theoretical models of preference reversal and econometric empirical analysis, this study finds that the number of calories eaten per meal increases and the quality of the diet decreases as people wait more than six hours to eat their next meal, work more than fifty hours a week, and consume a larger amount of food away from home. These situational factors are important even for consumers who have considerable knowledge about diet and health. Regardless of one's favored dietary prescription, this study shows how well an individual's intentions to eat healthfully changes with time pressures, hunger, and food source. As people change their dietary goals based on prevailing nutritional lore, such situational factors will continue to interfere with one's long-term health objectives. This is especially relevant in an era where obesity is a leading health issue for individuals and for the costs of health care. Any advice and action that can improve diet quality and reduce caloric intake on a convenient basis is valuable for individuals and the overall economy.Food Consumption/Nutrition/Food Safety,
Early suppression of lymphoproliferative response in dogs with natural infection by Leishmania infantum.
Dogs are the domestic reservoirs of zoonotic visceral leishmaniasis caused by Leishmania
infantum. Early detection of canine infections evolving to clinically patent disease may be
important to leishmaniasis control. In this study we firstly investigated the peripheral blood
mononuclear cell (PBMC) response to leishmanial antigens and to polyclonal activators
concanavalin A, phytohemagglutinin and pokeweed mitogen, of mixed-breed dogs with natural
L. infantum infection, either in presymptomatic or in patent disease condition, compared to healthy
animals. Leishmania antigens did not induce a clear proliferative response in any of the animals
examined. Furthermore, mitogen-induced lymphocyte proliferation was found strongly reduced not
only in symptomatic, but also in presymptomatic dogs suggesting that the cell-mediated immunity
is suppressed in progressive canine leishmaniasis. To test this finding, naive Beagle dogs were
exposed to natural L. infantum infection in a highly endemic area of southern Italy. Two to 10
months after exposure all dogs were found to be infected by Leishmania, and on month 2 of
exposure they all showed a significant reduction in PBMC activation by mitogens. Our results
indicate that suppression of the lymphoproliferative response is a common occurrence in dogs
already at the beginning of an established leishmanial infection. # 1999 Elsevier Science B.V. All
rights reserved
OFF LABEL USE OF POWER INJECTABLE DOUBLE LUMEN PICCS FOR APHERESIS AND HEMODIAFILTRATION IN NEONATES AND CHILDREN
Combined use of coenzyme Q10 and citicoline: A new possibility for patients with glaucoma
Glaucoma is the leading cause of irreversible blindness worldwide. Several risk factors have been involved in the pathogenesis of the disease. By now, the main treatable risk factor is elevated intraocular pressure. Nevertheless, some patients, whose intraocular pressure is considered in the target level, still experience a progression of the disease. Glaucoma is a form of multifactorial ocular neurodegeneration with complex etiology, pathogenesis, and pathology. New evidence strongly suggests brain involvement in all aspects of this disease. This hypothesis and the need to prevent glaucomatous progression led to a growing interest in the pharmacological research of new neuroprotective, non-IOP-lowering, agents. The aim of this paper is to report evidence of the usefulness of Coenzyme Q10 and Citicoline, eventually combined, in the prevention of glaucomatous neurodegeneration
Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis.
Significant relief of bone pain in patients with bone metastases was observed in a clinical trial of the epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor gefitinib in breast cancer. Osteoclast activation and differentiation are regulated by bone marrow stromal cells (BMSC), a heterogeneous cell compartment that comprehends undifferentiated mesenchymal stem cells (MSC) and their specialized progeny. In this regard, we found that human primary BMSCs express immunoreactive EGFR. Expression of EGFR mRNA and protein was also demonstrated in two human, continuous MSC-like cell lines, HDS-1 and HDS-2 cells. Treatment of HDS cells with EGF produced a significant increase in the levels of activated EGFR which was not observed in the presence of gefitinib. A significant reduction in the basal levels of activation of the EGFR and of Akt was observed in HDS cells following treatment with gefitinib. Treatment of HDS cells with gefitinib produced a significant reduction in the levels of secreted macrophage colony-stimulating factor (M-CSF) and cell-associated receptor activator of NF-kappaB ligand (RANKL) in both cell lines, as assessed by using specific ELISA and Western blotting techniques. Finally, the ability to sustain the differentiation of pre-osteoclasts of conditioned medium from gefitinib-treated HDS cells was reduced by approximately 45% as compared with untreated HDS cells. These data have demonstrated for the first time that the EGFR regulates the ability of BMSCs to induce osteoclast differentiation and strongly support clinical trials of gefitinib in breast cancer patients with bone disease
Lipid peroxidation and total anitoxidant capacity in vitreous, aqueous humor and blood samples from patients with diabetric retinopathy
The NANOG transcription factor induces type 2 deiodinase expression and regulates the intracellular activation of thyroid hormone in keratinocyte carcinomas
Type 2 deiodinase (D2), the principal activator of thyroid hormone (TH) signaling in target tissues, is expressed in cutaneous squamous cell carcinomas (SCCs) during late tumorigenesis, and its repression attenuates the invasiveness and metastatic spread of SCC. Although D2 plays multiple roles in cancer progression, nothing is known about the mechanisms regulating D2 in cancer. To address this issue, we investigated putative upstream regulators of D2 in keratinocyte carcinomas. We found that the expression of D2 in SCC cells is positively regulated by the NANOG transcription factor, whose expression, besides being causally linked to embryonic stemness, is associated with many human cancers. We also found that NANOG binds to the D2 promoter and enhances D2 transcription. Notably, blockage of D2 activity reduced NANOG-induced cell migration as well as the expression of key genes involved in epithelial–mesenchymal transition in SCC cells. In conclusion, our study reveals a link among endogenous endocrine regulators of cancer, thyroid hormone and its activating enzyme, and the NANOG regulator of cancer biology. These findings could provide the basis for the development of TH inhibitors as context-dependent anti-tumor agents
Smart Dairy Farming: Innovative Solutions to Improve Herd Productivity
Among the most straining trends that farmers have to face there are: on one side, to guarantee welfare and adequate life conditions for animals and to reduce the environmental footprint, on the other side, to develop new strategies to improve farm management reducing costs. The current conditions and the expected developments of the dairy sector highlight a strong need for more efficient and sustainable farming systems. Studying heat stress, herd management and housing and animals\u2019 productive and reproductive performances is fundamental for the economic and environmental sustainability of the dairy chain. New and effective tools to cope with these challenges have been provided by Precision Livestock Farming (PLF), which is nowadays increasingly applied and makes possible to control quali-quantitative parameters related to production, health, behaviour, and real-time locomotion per animal. The research key challenge is to turn these data into knowledge to provide real-time support in farming optimisation. This research focuses specifically on different systems to collect, process and derive useful information from data on animal welfare and productivity. A multi-disciplinary approach has been adopted to generate a decision support system for farmers
- …